Health

Business Wire Australia and New Zealand

Orthocell Granted European Tendon Regeneration Patent

15-Dec-2017 11:14 AM
The European Patent Office has granted a patent entitled ‘Culture medium, culturing method and use of tenocytes’ Patent covers the method of manufacturing tendon regeneration cells (Tenocytes) to form the Autologous Tenocyte Implantation (Or

Business Wire Australia and New Zealand

BioVectra and Keryx Biopharmaceuticals Enter Agreement for Ferric Citrate Production Expansion

15-Dec-2017 9:57 AM
CHARLOTTETOWN, Prince Edward Island--(BUSINESS WIRE)--BioVectra Inc., an innovative global contract development and manufacturing organization (CDMO), today announced a long-term supply agreement with Keryx Biopharmaceuticals, Inc., to manu

University of Auckland

Potential new treatment and blood test for babies born too small

14-Dec-2017 1:00 PM
New Zealand research could pave the way for a new, safe treatment for babies whose growth in the womb is stunted by problems with the placenta. The research team have also discovered a possible basis for a blood test for mothers that could identify at-risk babies in utero.

Business Wire Australia and New Zealand

Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 2017

12-Dec-2017 8:16 AM
New Industry and Academic Partnerhips Build on Company’s Succeses and Reinforce Vision for the Future RIDGEFIELD, Conn. & INGELHEIM, Germany--(BUSINESS WIRE)--2017 marks a year of significant advancement for Boehringer Ingelh

Business Wire Australia and New Zealand

AstraZeneca’s Calquence (acalabrutinib) Shows Potential in Chronic Lymphocytic Leukaemia Trials

11-Dec-2017 10:54 AM
Data from two Phase I/II trials presented at American Society of Hematology Annual Meeting on efficacy and safety profile of acalabrutinib as monotherapy and combination treatment1,2 Findings highlight overall response rates and emerging s

Business Wire Australia and New Zealand

Celgene Corporation and bluebird bio Announce Updated Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti-BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting

11-Dec-2017 7:44 AM
SUMMIT, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) and bluebird bio, Inc. (Nasdaq: BLUE) today announced that updated results from the ongoing CRB-401 Phase 1 clinical study of bb2121, an invest

Business Wire Australia and New Zealand

Takeda and Seattle Genetics to Present Positive Data from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma

11-Dec-2017 7:41 AM
– Data will be Featured in the Plenary Scientific Session on December 10, 2017 with Simultaneous Publication in the New England Journal of Medicine – – Randomized Phase 3 Clinical Trial with ADCETRIS Met Primary Endpoint, Demon

Business Wire Australia and New Zealand

AstraZeneca’s Calquence (acalabrutinib) Demonstrates Activity in Relapsed or Refractory Mantle Cell Lymphoma Trial

10-Dec-2017 6:19 PM
81% overall response rate and 40% complete response rate by investigator assessment with consistent results observed across pre-specified subgroups of patients1   CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca and Acerta Pharma, its ha

Business Wire Australia and New Zealand

Orthocell Commences Treatment of Its 1,000th Patient

07-Dec-2017 11:46 AM
Orthocell commences treatment of its 1,000th patient from its TGA licensed facility Underpins the extensive clinical validation of Orthocell’s revenue-stage Ortho-ATI® and Ortho-ACI® therapies for the repair and regenerat

Business Wire Australia and New Zealand

MintHealth Announces Vidamints (VIDA) to Align Stakeholders in a New Healthcare Ecosystem

06-Dec-2017 9:33 AM
  Immediate Availability of White Paper Outlining Incentive Token to Engage and Empower Patients in Their Journey to Better Health Healthcare Reform Leader, “Tee” Green, Joins Board of Directors SAN DIEGO--(BUSINESS WIRE)--M

Business Wire Australia and New Zealand

PMC Group International Announces Acquisition of Pharma Company in France

05-Dec-2017 7:11 PM
  MOUNT LAUREL, N.J.--(BUSINESS WIRE)--PMC Group France, a wholly owned subsidiary of PMC Group International Inc., which is an independent arm of PMC Group Inc., announced the acquisition of the pharma business of Isochem SAS of France. This

Business Wire Australia and New Zealand

Netcare Teams Up with Germ-Zapping Robots to Take War on ‘Superbugs’ to a New Level

05-Dec-2017 9:08 AM
SANDTON, South Africa--(BUSINESS WIRE)--Healthcare facilities the world over face a daily challenge to prevent the spread of infections and, with increasing concern about antibiotic resistance, South African healthcare group Netcare 

Business Wire Australia and New Zealand

Herbalife Nutrition Appoints Renowned Thai Sports Medicine Expert to Its Nutrition Advisory Board

04-Dec-2017 3:53 PM
Dr. Korakod Panich joins Herbalife Nutrition Advisory Board. (Photo: Business Wire) BANGKOK--(BUSINESS WIRE)--In helping the world live happier and healthier, premier global nutrition company Herbalife (NYSE:HLF), announced today the appoi

Business Wire Australia and New Zealand

Artemis Hospital Becomes First in India to Adopt Masimo Patient SafetyNet™ Across All Hospital Care Areas

01-Dec-2017 5:47 PM
Supplemental Patient Surveillance System, in Conjunction with Masimo SET® and rainbow® Monitors, Provides Continuous Remote Monitoring 24 Hours a Day GURGAON, India--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that Ar

Business Wire Australia and New Zealand

Takeda Initiates Phase 1 Clinical Trial of Zika Vaccine Candidate

29-Nov-2017 9:51 AM
Takeda’s investigational Zika virus vaccine candidate (TAK-426) progresses into Phase 1 clinical trial The clinical trial (ZIK-101) will evaluate safety and immunogenicity of TAK-426 in 240 subjects between the ages of 18 and 49 acro

Business Wire Australia and New Zealand

Public Invited to Shape Foundation for a Smoke-Free World’s $1 Billion Research Agenda

29-Nov-2017 9:43 AM
Foundation Calls for Input on Research Priorities and Letters of Intent for Early Scoping Grants NEW YORK--(BUSINESS WIRE)--The Foundation for a Smoke-Free World is launching two online processes to inform and guide the Foundation’s

Business Wire Australia and New Zealand

New Independent Study Results Add to Growing Body of Evidence That PREVENA™ Therapy Helps Reduce Surgical Site Infections and Complications

28-Nov-2017 9:10 AM
Study concludes that total arthroplasty patients treated with PREVENA™ Therapy were four times less likely to experience surgical site complications compared with traditional gauze dressing SAN ANTONIO--(BUSINESS WIRE)--New inde

Business Wire Australia and New Zealand

Ferring Receives Swiss Approval For Rekovelle®, The First Personalised Fertility Treatment Using an Approved Dosing Algorithm

27-Nov-2017 5:31 PM
Rekovelle® provides doctors with an approved, evidence-based, individualised dosing regimen to personalise fertility treatment Approval expands options for fertility patients in Switzerland, providing a new and tailored approach to help

University of Auckland

Study of artist’s toilet tissues sheds light on gut bugs

26-Nov-2017 7:25 AM
In an intriguing collaboration between art and science, New Zealand scientists have compared the bacteria on artist, Billy Apple’s 46-year-old used toilet tissues to 2016 samples from the artist. Their findings substantiate growing evidence that a “core” part of our bacteria population remains stable as we age, and that at least some of the bacteria are actively selected by our genes.

Business Wire Australia and New Zealand

Boehringer Ingelheim Makes Many of Its Best Molecules Openly Available to the Scientific Community Via opnMe.com To Unlock Their Full Potential

21-Nov-2017 7:25 AM
opnME.com provides scientists with many best-in-class tool molecules supported by comprehensive data packages on one centralized platform for researchers to use The platform offers direct access to molecules for independent research